Published in Neurology on July 28, 2009
In vivo identification of morphologic retinal abnormalities in neuromyelitis optica. Neurology (2013) 2.43
Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis. Brain (2011) 2.21
Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS). J Neurol (2013) 1.79
Optical coherence tomography (OCT): imaging the visual pathway as a model for neurodegeneration. Neurotherapeutics (2011) 1.57
The retina as a window to the brain-from eye research to CNS disorders. Nat Rev Neurol (2012) 1.41
Neuromyelitis optica: clinical features, immunopathogenesis and treatment. Clin Exp Immunol (2014) 1.38
Evaluation of inner retinal layers in patients with multiple sclerosis or neuromyelitis optica using optical coherence tomography. Ophthalmology (2012) 1.34
Agreement between retinal nerve fiber layer measures from Spectralis and Cirrus spectral domain OCT. Optom Vis Sci (2012) 1.33
Neuromyelitis optica and multiple sclerosis: Seeing differences through optical coherence tomography. Mult Scler (2015) 1.30
Optical Coherence Tomography Reveals Distinct Patterns of Retinal Damage in Neuromyelitis Optica and Multiple Sclerosis. PLoS One (2013) 1.18
Optic neuritis is associated with inner nuclear layer thickening and microcystic macular edema independently of multiple sclerosis. PLoS One (2013) 1.13
Neuromyelitis optica: an antibody-mediated disorder of the central nervous system. Neurol Res Int (2012) 1.10
Neuromyelitis optica and the evolving spectrum of autoimmune aquaporin-4 channelopathies: a decade later. Ann N Y Acad Sci (2015) 1.07
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: Afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients. J Neuroinflammation (2016) 1.01
Optical coherence tomography in multiple sclerosis and neuromyelitis optica: an update. Mult Scler Int (2011) 0.97
Evaluating the use of optical coherence tomography in optic neuritis. Mult Scler Int (2011) 0.96
OCT: New perspectives in neuro-ophthalmology. Saudi J Ophthalmol (2014) 0.95
Retinal alterations in mild cognitive impairment and Alzheimer's disease: an optical coherence tomography study. J Neurol (2014) 0.93
Reliability and validity of Cirrus and Spectralis optical coherence tomography for detecting retinal atrophy in Alzheimer's disease. Eye (Lond) (2014) 0.92
Optical coherence tomography assessed retinal nerve fiber layer thickness in patients with Alzheimer's disease: a meta-analysis. Int J Ophthalmol (2012) 0.92
Idiopathic transverse myelitis and neuromyelitis optica: clinical profiles, pathophysiology and therapeutic choices. Curr Neuropharmacol (2011) 0.91
Optic neuritis in neuromyelitis optica. Prog Retin Eye Res (2013) 0.90
Subclinical primary retinal pathology in neuromyelitis optica spectrum disorder. J Neurol (2016) 0.90
Prospective study on retinal nerve fibre layer thickness changes in isolated unilateral retrobulbar optic neuritis. ScientificWorldJournal (2013) 0.84
The treatment of neuromyelitis optica. J Neuroophthalmol (2014) 0.84
How strong is the relationship between glaucoma, the retinal nerve fibre layer, and neurodegenerative diseases such as Alzheimer's disease and multiple sclerosis? Eye (Lond) (2015) 0.84
Imaging the visual pathway in neuromyelitis optica. Mult Scler Int (2011) 0.83
Analysis of the visual system in Friedreich ataxia. J Neurol (2013) 0.83
Optic nerve head quantification in idiopathic intracranial hypertension by spectral domain OCT. PLoS One (2012) 0.83
Macular thickness measurements with frequency domain-OCT for quantification of axonal loss in chronic papilledema from pseudotumor cerebri syndrome. Eye (Lond) (2014) 0.82
Complement-independent retinal pathology produced by intravitreal injection of neuromyelitis optica immunoglobulin G. J Neuroinflammation (2016) 0.81
Impact of the anti-aquaporin-4 autoantibody on inner retinal structure, function and structure-function associations in Japanese patients with optic neuritis. PLoS One (2017) 0.80
Optic neuritis in Hong Kong: a 1-year follow-up study. Int Ophthalmol (2014) 0.80
Macular sub-layer thinning and association with pulmonary function tests in Amyotrophic Lateral Sclerosis. Sci Rep (2016) 0.79
Effects of vitamin D on retinal nerve fiber layer in vitamin D deficient patients with optic neuritis: Preliminary findings of a randomized, placebo-controlled trial. J Res Med Sci (2015) 0.78
Analysis of Retinal Peripapillary Segmentation in Early Alzheimer's Disease Patients. Biomed Res Int (2015) 0.78
Time-Domain and Spectral-Domain Optical Coherence Tomography of Retinal Nerve Fiber Layer in MS Patients and Healthy Controls. J Ophthalmol (2012) 0.78
Optical coherence tomography (OCT) in optic neuritis and multiple sclerosis. Rev Neurol (Paris) (2010) 0.77
Ophthalmic Manifestations of Amyotrophic Lateral Sclerosis (An American Ophthalmological Society Thesis). Trans Am Ophthalmol Soc (2015) 0.77
Features of anti-aquaporin 4 antibody-seropositive Chinese patients with neuromyelitis optica spectrum optic neuritis. J Neurol (2015) 0.76
Quantifying visual pathway axonal and myelin loss in multiple sclerosis and neuromyelitis optica. Neuroimage Clin (2016) 0.76
Structural Alterations of Segmented Macular Inner Layers in Aquaporin4-Antibody-Positive Optic Neuritis Patients in a Chinese Population. PLoS One (2016) 0.76
Pattern electroretinogram in neuromyelitis optica and multiple sclerosis with or without optic neuritis and its correlation with FD-OCT and perimetry. Doc Ophthalmol (2013) 0.75
Longitudinal Changes in Retinal Nerve Fibre Layer Thickness after an Isolated Unilateral Retrobulbar Optic Neuritis: 1-Year Results. Neuroophthalmology (2015) 0.75
Inflammatory Optic Neuritis: From Multiple Sclerosis to Neuromyelitis Optica. Neuroophthalmology (2013) 0.75
Optical Coherence Tomography and Magnetic Resonance Imaging in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder. Int J Mol Sci (2016) 0.75
Retinal nerve fiber layer thickness in amnestic mild cognitive impairment: Case-control study and meta-analysis. Alzheimers Dement (Amst) (2016) 0.75
White matter disease: Early treatment of inflammatory demyelinating disease. Nat Rev Neurol (2013) 0.75
Neuromyelitis Optica Spectrum Disorder in a Chinese Woman with Ocular Myasthenia Gravis: First Reported Case in the Chinese Population. Neuroophthalmology (2014) 0.75
Longitudinally extensive optic neuritis as an MRI biomarker distinguishes neuromyelitis optica from multiple sclerosis. J Neurol Sci (2015) 0.75
Evaluation of Retinal Nerve Fiber Layer and Ganglion Cell Complex in Patients with Optic Neuritis or Neuromyelitis Optica Spectrum Disorders Using Optical Coherence Tomography in a Chinese Cohort. J Ophthalmol (2015) 0.75
Fibromyalgia Is Correlated with Retinal Nerve Fiber Layer Thinning. PLoS One (2016) 0.75
Retinal Morphology and Sensitivity Are Primarily Impaired in Eyes with Neuromyelitis Optica Spectrum Disorder (NMOSD). PLoS One (2016) 0.75
Finding NMO: The Evolving Diagnostic Criteria of Neuromyelitis Optica. J Neuroophthalmol (2016) 0.75
Macular changes of neuromyelitis optica through spectral-domain optical coherence tomography. Int J Ophthalmol (2016) 0.75
Myelin-oligodendrocyte-glycoprotein (MOG) autoantibodies as potential markers of severe optic neuritis and subclinical retinal axonal degeneration. J Neurol (2016) 0.75
Retinal thinning in amyotrophic lateral sclerosis patients without ophthalmic disease. PLoS One (2017) 0.75
Olfactory dysfunction in neuromyelitis optica spectrum disorders. J Neurol (2015) 0.75
[Optic nerve neuritis]. Ophthalmologe (2013) 0.75
Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol (2005) 24.22
Revised diagnostic criteria for neuromyelitis optica. Neurology (2006) 17.57
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet (2004) 13.18
Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. Ophthalmology (2006) 4.72
Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis. Neurology (2007) 4.72
Quantifying axonal loss after optic neuritis with optical coherence tomography. Ann Neurol (2006) 3.73
Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis. Ann Neurol (2005) 3.45
Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol (2006) 2.80
Optical coherence tomography and disease subtype in multiple sclerosis. Neurology (2007) 2.56
Neuromyelitis optica is distinct from multiple sclerosis. Arch Neurol (2007) 2.45
Correlation between morphological and functional retinal impairment in multiple sclerosis patients. Invest Ophthalmol Vis Sci (1999) 2.27
An investigation of the retinal nerve fibre layer in progressive multiple sclerosis using optical coherence tomography. Brain (2007) 2.18
NMO-IgG in the diagnosis of neuromyelitis optica. Neurology (2007) 1.77
A secondary progressive clinical course is uncommon in neuromyelitis optica. Neurology (2007) 1.70
Characterizing the mechanisms of progression in multiple sclerosis: evidence and new hypotheses for future directions. Arch Neurol (2005) 1.69
Retinal peripapillary nerve fiber layer thickness in neuromyelitis optica. Invest Ophthalmol Vis Sci (2008) 1.22
Optical coherence tomography in neuromyelitis optica. Arch Neurol (2008) 1.20
NMO-IgG and Devic's neuromyelitis optica: a French experience. Mult Scler (2008) 1.12
Progressive necrotizing myelopathy: part of the spectrum of neuromyelitis optica? Neurol Res (2006) 0.84
Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis. Neurology (2007) 4.72
Use of technology in children's dietary assessment. Eur J Clin Nutr (2009) 4.15
Anthropometric measurement error and the assessment of nutritional status. Br J Nutr (1999) 3.90
Association of human herpes virus 6 (HHV-6) with multiple sclerosis: increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA. Nat Med (1997) 3.65
Odontogenic tumors: analysis of 706 cases. J Oral Surg (1978) 3.32
The utility of MRI in suspected MS: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology (2003) 3.21
Optical coherence tomography and disease subtype in multiple sclerosis. Neurology (2007) 2.56
The King-Devick test as a determinant of head trauma and concussion in boxers and MMA fighters. Neurology (2011) 2.51
Measuring Friedreich ataxia: complementary features of examination and performance measures. Neurology (2006) 2.17
MRI of the corpus callosum in multiple sclerosis: association with disability. Mult Scler (2010) 2.13
Relation of vision to global and regional brain MRI in multiple sclerosis. Neurology (2007) 1.89
Idiopathic transverse myelitis: corticosteroids, plasma exchange, or cyclophosphamide. Neurology (2007) 1.74
Acute transverse myelitis in childhood: center-based analysis of 47 cases. Neurology (2007) 1.70
Quantitative characterization of the corticospinal tract at 3T. AJNR Am J Neuroradiol (2006) 1.62
Aven, a novel inhibitor of caspase activation, binds Bcl-xL and Apaf-1. Mol Cell (2000) 1.62
Saccade preparation inhibits reorienting to recently attended locations. J Exp Psychol Hum Percept Perform (1989) 1.55
Recurrent transverse myelitis associates with anti-Ro (SSA) autoantibodies. Neurology (2004) 1.55
Ethics of placebo-controlled clinical trials in multiple sclerosis: a reassessment. Neurology (2008) 1.53
A longitudinal study of the effect of sodium and calcium intakes on regional bone density in postmenopausal women. Am J Clin Nutr (1995) 1.50
Associations between retinal nerve fiber layer abnormalities and optic nerve examination. Neurology (2010) 1.49
Natalizumab reduces visual loss in patients with relapsing multiple sclerosis. Neurology (2007) 1.45
Increased serum levels of soluble CD95 (APO-1/Fas) in relapsing-remitting multiple sclerosis. Ann Neurol (1998) 1.45
Immune reconstitution inflammatory syndrome in the CNS of HIV-infected patients. Neurology (2006) 1.45
Visual impairment associated with mutism after posterior fossa surgery in children. Neurosurgery (1998) 1.44
Sixth nerve palsy as a presenting sign of intracranial plasmacytoma and multiple myeloma. J Neuroophthalmol (2000) 1.43
Low-contrast letter acuity testing captures visual dysfunction in patients with multiple sclerosis. Neurology (2005) 1.43
Morphological characteristics of Olympic sprint canoe and kayak paddlers. J Sci Med Sport (2003) 1.29
Longitudinal changes in diffusion tensor-based quantitative MRI in multiple sclerosis. Neurology (2011) 1.27
Behavioral and pathological outcomes in MOG 35-55 experimental autoimmune encephalomyelitis. J Neuroimmunol (2008) 1.26
Squamous odontogenic tumor. Report of six cases of a previously undescribed lesion. Oral Surg Oral Med Oral Pathol (1975) 1.24
Vision related quality of life in multiple sclerosis: correlation with new measures of low and high contrast letter acuity. J Neurol Neurosurg Psychiatry (2009) 1.22
The odontogenic adenomatoid tumor. A comprehensive study of twenty new cases. Oral Surg Oral Med Oral Pathol (1975) 1.21
Herpes simplex encephalitis and bilateral acute retinal necrosis syndrome after craniotomy. Am J Ophthalmol (1998) 1.19
Corticospinal tract abnormalities are associated with weakness in multiple sclerosis. AJNR Am J Neuroradiol (2007) 1.17
Assessment: vestibular testing techniques in adults and children: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology (2000) 1.16
Neuronal (type I) nitric oxide synthase regulates nuclear factor kappaB activity and immunologic (type II) nitric oxide synthase expression. Proc Natl Acad Sci U S A (1997) 1.15
Assessing disability progression with the Multiple Sclerosis Functional Composite. Mult Scler (2009) 1.15
Cooperative action of cellular proteins YB-1 and Pur alpha with the tumor antigen of the human JC polyomavirus determines their interaction with the viral lytic control element. Proc Natl Acad Sci U S A (1995) 1.11
Multiple sclerosis conference synopsis and discussion: cellular therapy for treatment of autoimmune diseases (October 2005). Mult Scler (2006) 1.09
Characterization of MRI response to treatment with interferon beta-1b: contrast-enhancing MRI lesion frequency as a primary outcome measure. Neurology (1997) 1.08
Idiopathic gingivostomatitis. Cheilitis, glossitis, gingivitis syndrome; atypical gingivostomatitis, plasma-cell gingivitis, plasmacytosis of gingiva. Oral Surg Oral Med Oral Pathol (1971) 1.06
Refractory giant cell arteritis with spinal cord infarction. Neurology (1997) 1.05
Effect of statins on clinical and molecular responses to intramuscular interferon beta-1a. Neurology (2009) 1.05
Requirement for safety monitoring for approved multiple sclerosis therapies: an overview. Clin Exp Immunol (2014) 1.00
Use of a portable head mounted perimetry system to assess bedside visual fields. Br J Ophthalmol (2000) 0.98
EFNS guidelines on the use of neuroimaging in the management of multiple sclerosis. Eur J Neurol (2006) 0.97
Optical coherence tomography does not support optic nerve involvement in amyotrophic lateral sclerosis. Eur J Neurol (2013) 0.96
Multiple idiopathic root resorption. Oral Surg Oral Med Oral Pathol (1970) 0.96
Fibrous lesions of the skin and mucous membranes which contain stellate and multinucleated cells. Oral Surg Oral Med Oral Pathol (1975) 0.96
Memantine for cognitive impairment in multiple sclerosis: a randomized placebo-controlled trial. Mult Scler (2010) 0.95
Effects of a 1-year randomized controlled trial of resistance training on lower limb bone and muscle structure and function in older men. Osteoporos Int (2010) 0.95
Retinal architecture predicts pupillary reflex metrics in MS. Mult Scler (2008) 0.94
14-3-3 protein in the cerebrospinal fluid of patients with acute transverse myelitis. Lancet (2000) 0.94
Weight gain and recurrence in idiopathic intracranial hypertension: a case-control study. Neurology (2011) 0.94
Allergic gingivostomatitis (due to gum chewing). J Periodontol (1971) 0.93
Diffusion tensor imaging of the optic nerve in multiple sclerosis: association with retinal damage and visual disability. AJNR Am J Neuroradiol (2011) 0.93
Isolated fourth nerve palsy from midbrain hemorrhage: case report. J Neuroophthalmol (1998) 0.92
The King-Devick test as a concussion screening tool administered by sports parents. J Sports Med Phys Fitness (2014) 0.91
Vitamin D status and effect of low-dose cholecalciferol and high-dose ergocalciferol supplementation in multiple sclerosis. Mult Scler (2009) 0.90
Somatotype and size of elite female basketball players. J Sports Sci (2005) 0.89
Correlates of intestinal calcium absorption in women 10 years past the menopause. Calcif Tissue Int (1993) 0.89
The Heidenhain variant of Creutzfeldt-Jakob disease: clinical, pathologic, and neuroimaging findings. J Neuroophthalmol (2001) 0.88
Randomized controlled trial of atorvastatin in clinically isolated syndrome: the STAyCIS study. Neurology (2012) 0.87
Interferon-beta-1b slows progression of atrophy in RRMS: Three-year follow-up in NAb- and NAb+ patients. Neurology (2004) 0.87
Equipment set-up among Olympic sprint and slalom kayak paddlers. Sports Biomech (2005) 0.87
Dental management of patients irradiated for oral cancer. Cancer (1976) 0.86
Avonex Combination Trial in relapsing--remitting MS: rationale, design and baseline data. Mult Scler (2008) 0.86
Under-reporting of energy intake in elderly Australian women is associated with a higher body mass index. J Nutr Health Aging (2013) 0.86
Results of the Avonex Combination Trial (ACT) in relapsing-remitting MS. Neurology (2009) 0.85
Supranuclear gaze palsy and opsoclonus after Diazinon poisoning. J Neurol Neurosurg Psychiatry (2003) 0.85
Interferon-beta-1a induces increases in vascular cell adhesion molecule: implications for its mode of action in multiple sclerosis. J Neuroimmunol (2005) 0.85
A phase I trial of solubilized DR2:MBP84-102 (AG284) in multiple sclerosis. Neurology (2000) 0.85
Plasma ferritin concentration and physical work capacity in athletes. Int J Sport Nutr (1992) 0.85
Venous hypertensive myelopathy as a potential mimic of transverse myelitis. Spinal Cord (2004) 0.85
Central neurogenic hyperventilation in an awake patient with a pontine glioma. Neurology (1996) 0.84
Pediatric optic neuritis: brain MRI abnormalities and risk of multiple sclerosis. Neurology (2009) 0.84
Proof of concept studies for tissue-protective agents in multiple sclerosis. Mult Scler (2009) 0.83
Overweight adolescents eat what? And when? Analysis of consumption patterns to guide dietary message development for intervention. J Hum Nutr Diet (2014) 0.83
Ictus expectoratus: a sign of complex partial seizures usually of non-dominant temporal lobe origin. Seizure (1999) 0.83
Relationship of the body mass index with skinfolds, girths, and bone breadths in Canadian men and women aged 20-70 years. Am J Phys Anthropol (1988) 0.83
Retinal findings in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (cadasil). Surv Ophthalmol (2001) 0.82
Thalidomide for acute treatment of neurosarcoidosis. Spinal Cord (2007) 0.82
Optimization of the safety and efficacy of interferon beta 1b and azathioprine combination therapy in multiple sclerosis. Mult Scler (2005) 0.81
Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis. Neurology (2008) 0.80
MRI studies of multiple sclerosis: implications for the natural history of the disease and for monitoring effectiveness of experimental therapies. Mult Scler (1996) 0.79
Physique characteristics of Pan American Games lightweight rowers. Int J Sports Med (1989) 0.79
Cup to disc ratio by optical coherence tomography is abnormal in multiple sclerosis. J Neurol Sci (2011) 0.79